Heart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency
- PMID: 19628114
- DOI: 10.1016/j.jacc.2009.05.012
Heart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency
Abstract
Objectives: We sought to evaluate the role of exercise-related changes in left ventricular (LV) relaxation and of LV contractile function and vasculoventricular coupling (VVC) in the pathophysiology of heart failure with preserved ejection fraction (HFpEF) and to assess myocardial energetic status in these patients.
Background: To date, no studies have investigated exercise-related changes in LV relaxation and VVC as well as in vivo myocardial energetic status in patients with HFpEF.
Methods: We studied 37 patients with HFpEF and 20 control subjects. The VVC and time to peak LV filling (nTTPF, a measure of LV active relaxation) were assessed while patients were at rest and during exercise by the use of radionuclide ventriculography. Cardiac energetic status (creatine phosphate/adenosine triphosphate ratio) was assessed by the use of (31)P magnetic resonance spectroscopy at 3-T.
Results: When patients were at rest, nTTPF and VVC were similar in patients with HFpEF and control subjects. The cardiac creatine phosphate/adenosine triphosphate ratio was reduced in patients with HFpEF versus control subjects (1.57 +/- 0.52 vs. 2.14 +/- 0.63; p = 0.003), indicating reduced energy reserves. Peak maximal oxygen uptake and the increase in heart rate during maximal exercise were lower in patients with HFpEF versus control subjects (19 +/- 4 ml/kg/min vs. 36 +/- 8 ml/kg/min, p < 0.001, and 52 +/- 16 beats/min vs. 81 +/- 14 beats/min, p < 0.001). The relative changes in stroke volume and cardiac output during submaximal exercise were lower in patients with HFpEF versus control subjects (ratio exercise/rest: 0.99 +/- 0.34 vs. 1.25 +/- 0.47, p = 0.04, and 1.36 +/- 0.45 vs. 2.13 +/- 0.72, p < 0.001). The nTTPF decreased during exercise in control subjects but increased in patients with HFpEF (-0.03 +/- 12 s vs. +0.07 +/- 0.11 s; p = 0.005). The VVC decreased on exercise in control subjects but was unchanged in patients with HFpEF (-0.01 +/- 0.15 vs. -0.25 +/- 0.19; p < 0.001).
Conclusions: Patients with HFpEF have reduced cardiac energetic reserve that may underlie marked dynamic slowing of LV active relaxation and abnormal VVC during exercise.
Comment in
-
Heart failure with preserved ejection fraction failure to preserve, failure of reserve, and failure on the compliance curve.J Am Coll Cardiol. 2009 Jul 28;54(5):419-21. doi: 10.1016/j.jacc.2009.05.011. J Am Coll Cardiol. 2009. PMID: 19628116 Free PMC article. No abstract available.
Similar articles
-
Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction.Circulation. 2006 Nov 14;114(20):2138-47. doi: 10.1161/CIRCULATIONAHA.106.632745. Epub 2006 Nov 6. Circulation. 2006. PMID: 17088459
-
Left ventricular abnormal response during dynamic exercise in patients with heart failure and preserved left ventricular ejection fraction at rest.J Card Fail. 2008 Aug;14(6):475-80. doi: 10.1016/j.cardfail.2008.02.012. Epub 2008 May 27. J Card Fail. 2008. PMID: 18672195
-
Impaired heart rate recovery and chronotropic incompetence in patients with heart failure with preserved ejection fraction.Circ Heart Fail. 2010 Jan;3(1):29-34. doi: 10.1161/CIRCHEARTFAILURE.109.877720. Epub 2009 Nov 16. Circ Heart Fail. 2010. PMID: 19917649
-
Cardiac dysfunction in heart failure: the cardiologist's love affair with time.Prog Cardiovasc Dis. 2006 Nov-Dec;49(3):157-81. doi: 10.1016/j.pcad.2006.08.010. Prog Cardiovasc Dis. 2006. PMID: 17084177 Review.
-
Clinical characteristics and outcomes of heart failure with preserved ejection fraction: lessons from epidemiological studies.J Cardiol. 2010 Jan;55(1):13-22. doi: 10.1016/j.jjcc.2009.09.003. Epub 2009 Nov 7. J Cardiol. 2010. PMID: 20122544 Review.
Cited by
-
Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction.Eur J Heart Fail. 2013 Jul;15(7):776-85. doi: 10.1093/eurjhf/hft026. Epub 2013 Feb 20. Eur J Heart Fail. 2013. PMID: 23426022 Free PMC article.
-
Drug Targets for Heart Failure with Preserved Ejection Fraction: A Mechanistic Approach and Review of Contemporary Clinical Trials.Annu Rev Pharmacol Toxicol. 2019 Jan 6;59:41-63. doi: 10.1146/annurev-pharmtox-010818-021136. Epub 2018 Oct 8. Annu Rev Pharmacol Toxicol. 2019. PMID: 30296895 Free PMC article. Review.
-
Mitochondrial Dysfunction in Heart Failure With Preserved Ejection Fraction.Circulation. 2019 Mar 12;139(11):1435-1450. doi: 10.1161/CIRCULATIONAHA.118.036259. Circulation. 2019. PMID: 30856000 Free PMC article. Review.
-
Heart failure with preserved ejection fraction: current understandings and challenges.Curr Cardiol Rep. 2014 Jul;16(7):501. doi: 10.1007/s11886-014-0501-8. Curr Cardiol Rep. 2014. PMID: 24893938 Review.
-
Heart Failure with Preserved Ejection Fraction: Mechanisms and Treatment Strategies.Annu Rev Med. 2022 Jan 27;73:321-337. doi: 10.1146/annurev-med-042220-022745. Epub 2021 Aug 11. Annu Rev Med. 2022. PMID: 34379445 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical